Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension

Sukhdeep Bhogal, Debabrata Mukherjee, Subhash Banerjee, Walter Tan, Timir K. Paul

Research output: Contribution to journalArticle

Abstract

Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.

Original languageEnglish (US)
Pages (from-to)191-216
Number of pages26
JournalCurrent Problems in Cardiology
Volume43
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Pulmonary Hypertension
Vascular Resistance
Disease Progression
Heart Failure
Pressure
Lung
Population
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension. / Bhogal, Sukhdeep; Mukherjee, Debabrata; Banerjee, Subhash; Tan, Walter; Paul, Timir K.

In: Current Problems in Cardiology, Vol. 43, No. 5, 01.05.2018, p. 191-216.

Research output: Contribution to journalArticle

Bhogal, Sukhdeep ; Mukherjee, Debabrata ; Banerjee, Subhash ; Tan, Walter ; Paul, Timir K. / Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension. In: Current Problems in Cardiology. 2018 ; Vol. 43, No. 5. pp. 191-216.
@article{afd4149711d14208aed1883ff002c605,
title = "Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension",
abstract = "Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1{\%} of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.",
author = "Sukhdeep Bhogal and Debabrata Mukherjee and Subhash Banerjee and Walter Tan and Paul, {Timir K.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.cpcardiol.2017.10.002",
language = "English (US)",
volume = "43",
pages = "191--216",
journal = "Current Problems in Cardiology",
issn = "0146-2806",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension

AU - Bhogal, Sukhdeep

AU - Mukherjee, Debabrata

AU - Banerjee, Subhash

AU - Tan, Walter

AU - Paul, Timir K.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.

AB - Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.

UR - http://www.scopus.com/inward/record.url?scp=85034756887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034756887&partnerID=8YFLogxK

U2 - 10.1016/j.cpcardiol.2017.10.002

DO - 10.1016/j.cpcardiol.2017.10.002

M3 - Article

C2 - 29174585

AN - SCOPUS:85034756887

VL - 43

SP - 191

EP - 216

JO - Current Problems in Cardiology

JF - Current Problems in Cardiology

SN - 0146-2806

IS - 5

ER -